1. Home
  2. SRRK vs PCTY Comparison

SRRK vs PCTY Comparison

Compare SRRK & PCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$49.35

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Paylocity Holding Corporation

PCTY

Paylocity Holding Corporation

HOLD

Current Price

$99.55

Market Cap

6.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
PCTY
Founded
2012
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.1B
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
SRRK
PCTY
Price
$49.35
$99.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
17
Target Price
$56.17
$176.59
AVG Volume (30 Days)
1.1M
674.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.74
EPS
N/A
3.81
Revenue
N/A
$1,595,221,000.00
Revenue This Year
N/A
$11.52
Revenue Next Year
$534.24
$7.98
P/E Ratio
N/A
$26.52
Revenue Growth
N/A
13.74
52 Week Low
$27.07
$92.99
52 Week High
$52.19
$197.78

Technical Indicators

Market Signals
Indicator
SRRK
PCTY
Relative Strength Index (RSI) 59.72 34.40
Support Level $45.46 $92.99
Resistance Level $51.55 $117.32
Average True Range (ATR) 2.07 4.06
MACD 0.38 -1.79
Stochastic Oscillator 92.50 2.12

Price Performance

Historical Comparison
SRRK
PCTY

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About PCTY Paylocity Holding Corporation

Paylocity is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. With the addition of expense and IT management modules, Paylocity unifies back-office operations spanning HR, finance, and IT on a single platform and bills customers on a subscription basis. The firm's customer base skews toward the midmarket and is primarily based in the US. As of fiscal 2025, Paylocity has nearly 42,000 customers.

Share on Social Networks: